NovaBay Pharmaceuticals, Inc. - stock earnings
NBY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | 3.3 million USD |
| 2023Q2 | -4.0 million USD | 4.6 million USD |
| 2023Q1 | -1.7 million USD | 3.1 million USD |
| 2022Q4 | -8.2 million USD | 3.6 million USD |
| 2022Q3 | -5.8 million USD | 3.8 million USD |
| 2022Q2 | -2.2 million USD | 3.0 million USD |
| 2022Q1 | -111000 USD | 2.6 million USD |
| 2021Q4 | -893000 USD | 2.6 million USD |
| 2021Q3 | -2.3 million USD | 1.8 million USD |
| 2021Q2 | -1.9 million USD | 2.1 million USD |
| 2021Q1 | -1.5 million USD | 1.8 million USD |
| 2020Q4 | -1.8 million USD | 1.9 million USD |
| 2020Q3 | -3.2 million USD | 2.2 million USD |
| 2020Q2 | -4.5 million USD | 4.0 million USD |
| 2020Q1 | -1.6 million USD | 1.9 million USD |
| 2019Q4 | -3.5 million USD | 1.7 million USD |
| 2019Q3 | -282000 USD | 1.6 million USD |
| 2019Q2 | -2.5 million USD | 1.8 million USD |
| 2019Q1 | -4.2 million USD | 1.5 million USD |
| 2018Q4 | -1.3 million USD | 3.6 million USD |
| 2018Q3 | -1.5 million USD | 3.1 million USD |
| 2018Q2 | -1.6 million USD | 2.8 million USD |
| 2018Q1 | -2.2 million USD | 2.9 million USD |
| 2017Q4 | 793000 USD | 6.3 million USD |
| 2017Q3 | -2.4 million USD | 4.1 million USD |
| 2017Q2 | -1.7 million USD | 4.1 million USD |
| 2017Q1 | -4.0 million USD | 3.7 million USD |
| 2016Q4 | -1.6 million USD | 4.1 million USD |
| 2016Q3 | -3.7 million USD | 3.4 million USD |
| 2016Q2 | -2.7 million USD | 2.7 million USD |
| 2016Q1 | -5.1 million USD | 1.7 million USD |
| 2015Q4 | -4.2 million USD | 1.6 million USD |
| 2015Q3 | -5.2 million USD | 1.2 million USD |
| 2015Q2 | -4.9 million USD | 1.0 million USD |
| 2015Q1 | -4.6 million USD | 538000 USD |
| 2014Q4 | -4.5 million USD | 491000 USD |
| 2014Q3 | -4.2 million USD | 152000 USD |
| 2014Q2 | -2.9 million USD | 123000 USD |
| 2014Q1 | -3.6 million USD | 288000 USD |
| 2013Q4 | -4.1 million USD | 510000 USD |
| 2013Q3 | -3.8 million USD | 1.1 million USD |
| 2013Q2 | -4.0 million USD | 848000 USD |
| 2013Q1 | -4.0 million USD | 1.0 million USD |
| 2012Q4 | -2.4 million USD | 1.1 million USD |
| 2012Q3 | 80000 USD | 3.6 million USD |
| 2012Q2 | -2.2 million USD | 871000 USD |
| 2012Q1 | -2.5 million USD | 1.3 million USD |
| 2011Q4 | -3.6 million USD | 1.2 million USD |
| 2011Q3 | 106000 USD | 2.8 million USD |
| 2011Q2 | 425000 USD | 4.5 million USD |
| 2011Q1 | -2.0 million USD | 2.5 million USD |
| 2010Q4 | 161000 USD | 3.0 million USD |
| 2010Q3 | -1.6 million USD | 2.1 million USD |
| 2010Q2 | -1.2 million USD | 2.5 million USD |
| 2010Q1 | -1.6 million USD | 2.1 million USD |
| 2009Q4 | 3.4 million USD | 7.5 million USD |
| 2009Q3 | -111000 USD | 3.2 million USD |
| 2009Q2 | -318000 USD | 2.6 million USD |
| 2009Q1 | -318000 USD | 2.6 million USD |
| 2008Q4 | -1.5 million USD | 2.2 million USD |
| 2008Q3 | -1.5 million USD | 1.6 million USD |
| 2008Q2 | -2.4 million USD | 1.4 million USD |
| 2008Q1 | -2.7 million USD | 1.5 million USD |
| 2007Q4 | -1.4 million USD | 1.5 million USD |
| 2007Q3 | -1.6 million USD | 1.4 million USD |
| 2007Q2 | -1.6 million USD | 1.5 million USD |
| 2007Q1 | -893000 USD | 1.5 million USD |
| 2006Q4 | -1.2 million USD | 1.3 million USD |
| 2006Q3 | -1.4 million USD | 208000 USD |
| 2006Q2 | -1.5 million USD | ? USD |
| 2006Q1 | -1.2 million USD | ? USD |
| 2005Q4 | -866000 USD | ? USD |
| 2005Q3 | -866000 USD | ? USD |
| 2005Q2 | -866000 USD | ? USD |
| 2005Q1 | -866000 USD | ? USD |
NBY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.7 million USD | 14.6 million USD |
| 2022 | -16.3 million USD | 14.4 million USD |
| 2021 | -6.6 million USD | 8.4 million USD |
| 2020 | -11.0 million USD | 9.9 million USD |
| 2019 | -10.5 million USD | 6.6 million USD |
| 2018 | -6.5 million USD | 12.5 million USD |
| 2017 | -7.4 million USD | 18.2 million USD |
| 2016 | -13.2 million USD | 11.9 million USD |
| 2015 | -19.0 million USD | 4.4 million USD |
| 2014 | -15.2 million USD | 1.1 million USD |
| 2013 | -16.0 million USD | 3.5 million USD |
| 2012 | -7.0 million USD | 6.9 million USD |
| 2011 | -5.1 million USD | 11.0 million USD |
| 2010 | -4.3 million USD | 9.8 million USD |
| 2009 | 2.7 million USD | 15.7 million USD |
| 2008 | -8.1 million USD | 6.7 million USD |
| 2007 | -5.4 million USD | 5.9 million USD |
| 2006 | -5.3 million USD | 1.5 million USD |
| 2005 | -3.5 million USD | ? USD |
| 2004 | -2.8 million USD | ? USD |
| 2003 | -977000 USD | ? USD |
NBY
Price: $0.09
52 week price:
Earnings Per Share: -7.05 USD
P/E Ratio: -0.02
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 100900
Market Capitalization: 3.0 million